Skip to content Skip to navigation

Medication

Portman, Ayotte among members of Congress recognized by opioid coalition

September 22, 2016  |  Gary A. Enos, Editor
news
U.S. Sens. Rob Portman and Kelly Ayotte, both facing high-profile re-election challenges this fall, are among eight members of Congress recognized this week for efforts to combat the opioid epidemic.

Younger adult overdoses on the rise in Virginia

September 21, 2016  |  Tom Valentino, Senior Editor
news
Adults ages 25 to 44 accounted for more than half of all drug overdose-related deaths in Virginia from 2007 to 2014, according to research published this week.

Alkermes establishes grant program for nonprofits

September 16, 2016  |  Gary A. Enos, Editor
news
The maker of injectable naltrexone has announced an initiative in which nonprofit organizations may apply for funding to improve addiction and mental health systems of care.

ASAM releases patient guide to opioid addiction treatment

September 2, 2016  |  Gary A. Enos, Editor
news
Assessment, treatment planning and medical interventions are addressed in the American Society of Addiction Medicine's (ASAM's) opioid treatment guide for patients and families.

Some doctors pursuing genetic clues to medication response or misuse

September 1, 2016  |  Gary A. Enos, Editor
article
Predictive testing to evaluate the potential risks and benefits of opioids and other medications appears to have wide applicability in many sectors of healthcare.

FDA mandates warnings, education on use of opioids with benzodiazepines

September 1, 2016  |  Gary A. Enos, Editor
news
Based partly on findings of increases in overdoses from concurrent prescribing of opioids and benzodiazepines, the Food and Drug Administration (FDA) is requiring boxed warnings and patient guides for nearly 400 individual drugs.

Researchers to launch human testing of anti-cocaine vaccine

August 9, 2016  |  Gary A. Enos, Editor
news
Researchers at two New York institutions are recruiting active cocaine users for Phase I testing of an anti-cocaine vaccine that has shown promise in animal research.

Significant prevalence of gabapentin misuse seen in pain patients

August 5, 2016  |  Gary A. Enos, Editor
news
Data presented this week at a national scientific meeting indicate that a significant number of prescription opioid users are misusing the anti-seizure medication gabapentin.

Data on concurrent use of heroin, benzodiazepines alarm researchers

August 2, 2016  |  Gary A. Enos, Editor
article
A Quest Diagnostics trends report has found that among patients who used heroin, nearly one in three also were using benzodiazepines, in a highly dangerous combination.

Weight-loss product containing naltrexone gets sales relaunch

August 2, 2016  |  Gary A. Enos, Editor
news
The weight-loss drug Contrave combines the opioid antagonist naltrexone and bupropion; Orexigen Therapeutics has completed its acquisition of its U.S. rights.

AATOD announces 2016 award recipients

July 25, 2016  |  Gary A. Enos, Editor
news
Patient advocate Brenda Davis and Office of National Drug Control Policy (ONDCP) director Michael Botticelli are among this year's honorees from the American Association for the Treatment of Opioid Dependence (AATOD).

Testing company launches trial in screening for genetic variables in drug response

July 22, 2016  |  Gary A. Enos, Editor
news
InSource Diagnostics is recruiting patients for a study employing urine testing to help determine which patients have a genetic mutation affecting response to drugs such as opioids.

Pages

Subscribe to Medication